Pethema Foundation
Clinical trials sponsored by Pethema Foundation, explained in plain language.
-
New protocol aims to boost survival in adult leukemia patients
Disease control Not yet recruitingThis study tests a new treatment plan for adults up to 65 years old with a type of leukemia called Ph-negative acute lymphoblastic leukemia. The goal is to see if adding an immunotherapy drug called blinatumomab improves survival compared to the previous treatment plan. About 330…
Phase: NA • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated May 26, 2026 08:49 UTC
-
New pill combo offers hope for older leukemia patients who Can't handle chemo
Disease control Not yet recruitingThis study tests whether taking two oral medications (decitabine and ivosidenib) together can help older adults (60+) or those with other health issues who have a specific genetic type of acute myeloid leukemia (AML). The goal is to see if the combination can put the leukemia int…
Phase: PHASE2 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated May 26, 2026 08:41 UTC
-
New hope for leukemia patients too fragile for chemo: Triple-Drug trial launches
Disease control Not yet recruitingThis study tests whether adding quizartinib to the usual two-drug therapy (venetoclax and azacytidine) helps adults with newly diagnosed acute myeloid leukemia (AML) live longer. Participants are 18 or older and cannot have standard chemotherapy due to age or health problems. Abo…
Phase: PHASE3 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated May 26, 2026 08:30 UTC